News
Hosted on MSN28d
501st Legion Troopers: Every Clone, Every Detail - MSNFrom Captain Rex to the lesser-known troopers who fought in the galaxy’s most iconic battles, this video breaks down every 501st Legion clone in detail. Dive into the rich lore, armor designs ...
Red Five on MSN12d
Star Wars: Clone Trooper Captains UncoveredThis video offers an in-depth exploration of the Clone Trooper Captains from the Star Wars universe, highlighting their ...
Star Wars Legion’s lead designers at Atomic Mass Games run through the capabilities of Obi-Wan Kenobi’s Galactic Republic ...
MindRank said 70.9% to 85.4% of patients achieved at least 5% weight loss. Between 34.5% and 48.1% achieved at least 10% weight loss. In Lilly’s phase 2b trial, up to 90% and 71% of patients ...
On June 1, Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or metastatic renal cell carcinoma/RCC during an oral ...
A total of 59.1% of the 1.2-mg cohort and 52.1% of the 1.8-mg cohort saw their MASH resolve without a worsening of fibrosis, compared to 19.1% of the placebo cohort, hitting one of the trial’s ...
SHANGHAI & CAMBRIDGE, Mass., June 02, 2025--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that updated data from an ongoing, global Phase 1a/1b clinical trial (NCT06179069) evaluating ...
Sionna plans to advance both NBD1 stabilizers to the next stage of clinical development — SION-719 to a Phase 2a proof-of-concept (POC) trial in CF patients as an add-on to SOC, and SION-451 to ...
We conducted a phase 1–2 study of zimislecel in persons with type 1 diabetes. In part A, participants received a half dose of zimislecel (0.4×10 9 cells) as a single infusion into the portal ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared positive topline results from the Phase 1 study of salanersen (IO ...
Additionally, Sagimet recently initiated a Phase 1 first-in-human clinical trial with a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results